enGene Holdings (NasdaqCM:ENGN) Update / Briefing November 11, 2025 08:00 AM ET Company ParticipantsRon Cooper - President and CEOSuzanne Merrill - Senior Physician, Urologic Oncologist and Bladder Cancer Regional LeadSean McCutcheon - VP of Biotechnology Equity ResearchLauren Hopfer - Executive Director of Investor RelationsHussein Sweiti - CMOConference Call ParticipantsLeland Gershell - Managing Director and Senior Biotechnology AnalystYanan Zhu - Senior AnalystDavid Dai - Senior Biotech AnalystSilvan Tü ...

Nebius Group (NasdaqGS:NBIS) Q3 2025 Earnings Call November 11, 2025 08:00 AM ET Company ParticipantsArkady Volozh - CEOAndrey Korolenko - Head of InfrastructureMarc Boroditsky - Chief Revenue OfficerTom Blackwell - CCOMaria del Dado Alonso Sanchez - CFONeil Doshi - VP of Investor RelationsRoman Chernin - CBONeil DoshiThank you, and welcome to Nebius Group's Third Quarter 2025 Earnings Conference Call. I'm Neil Doshi, Vice President of Investor Relations. Joining me today are Arkady Volozh, Founder and CEO, ...

Mt. Hamilton, NV US Fully Funded Gold Production Growth in the Americas with Tungsten Optionality Zurich | November 2025 TSX-V: MKO | OTCQX: MAKOF Moss Mine, AZ US Eagle Mountain Project, Guyana San Albino Mine, Nicaragua Forward Looking Information This document contains "forward-looking information" and "financial outlook" within the meaning of applicable Canadian securities laws. Statements containing forward-looking information are not historical facts but instead represent the C ompany's expectations, ...

Recursion Pharmaceuticals (NasdaqGS:RXRX) FY Conference November 11, 2025 08:00 AM ET Company ParticipantsBen Taylor - CFONajat Khan - Chief R&D and Commercial OfficerConference Call ParticipantsNone - AnalystNoneThanks, everyone, for joining us for our Second Day of our Second Annual Guggenheim Healthcare Innovation Conference. I'm Bommel Devon, for those of you who may not know me, one of the biopharma Analyst here. Also, at the end of the line here, our Sydney Shepherd-Villi is also from the Guggenheim s ...

Endava (NYSE:DAVA) Q1 2026 Earnings Call November 11, 2025 08:00 AM ET Speaker0Good day, and welcome to Endava's first quarter fiscal year 2026 conference call. All participants will be in a listen-only mode. Should you need assistance, please signal a conference specialist by pressing the star key followed by zero. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star, then one on a touch-tone phone. To withdraw your question, please press star, th ...

Precision BioSciences (NasdaqCM:DTIL) Update / Briefing November 11, 2025 08:00 AM ET Speaker3Thank you for standing by. My name is Tina, and I will be your conference operator today. At this time, I would like to welcome everyone to the Precision BioSciences AASLD update call. All lines have been placed on mute to prevent any background noise. After this speaker's remarks, there will be a question-and-answer session. To ask a question, simply press star followed by the number one on your telephone keypad. ...

Harrow (NasdaqGM:HROW) Q3 2025 Earnings Call November 11, 2025 08:00 AM ET Speaker3Good day, and welcome to the Harrow Third Quarter 2025 earnings conference call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there'll be a question-and-answer session. Instructions will be given at that time. As a reminder, this call may be recorded. I would like to turn the call over to Mike Biega, Vice President of Investor Relations and Communications. Please go ahead.Speaker ...

November 2025 Investor Presentation tdw.com Forward-looking Statements This presentation contains "forward-looking statements" within the meaning of the U.S. federal securities laws – that is, any statements that are not historical facts. Such statements often contain words such as "expect," "believe," "think," "anticipate," "predict," "plan," "assume," "estimate," "forecast," "target," "projections," "intend," "should," "will," "shall" and other similar words. Forward-looking statements address matters tha ...

Crescent Biopharma (:) FY Conference November 11, 2025 08:00 AM ET Company ParticipantsJosh Brumm - CEOEllie Im - CMOConference Call ParticipantsBrad Cannino - Biotechnology Equity Research AnalystBrad CanninoKick it off here for the first fireside of the day. My name is Brad Cannino. Thank you for joining us at the Guggenheim Second Annual Healthcare Innovation Conference. Happy to do the fireside today with Crescent Biopharma. We've got Josh Brumm, CEO, Ellie Im, CMO, on the stage with me. Josh, maybe if ...

Investor Presentation Q3 2025 Results NASDAQ: WPRT / TSX: WPRT Speaking Today... November 11, 2025 Westport Fuel Systems Disclaimer and Forward-Looking Statements This presentation contains forward-looking statements that are based on the beliefs of management and reflects our current expectations as contemplated under the safe harbor provisions of Section 21E of the United States Securities Act of 1934, as amended. Such forward-looking statements include, but are not limited to, future strategic initiative ...